Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-013004
Filing Date
2025-05-30
Accepted
2025-05-30 15:39:49
Documents
85

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm   iXBRL S-1/A 5126916
2 EX-1.1 ex1-1.htm EX-1.1 532970
3 EX-5.1 ex5-1.htm EX-5.1 28341
4 EX-23.1 ex23-1.htm EX-23.1 4279
5 GRAPHIC ex5-1_001.jpg GRAPHIC 4262
6 GRAPHIC logo_001.jpg GRAPHIC 68479
  Complete submission text file 0001641172-25-013004.txt   19911286

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ppcb-20250331.xsd EX-101.SCH 84574
8 XBRL CALCULATION FILE ppcb-20250331_cal.xml EX-101.CAL 85410
9 XBRL DEFINITION FILE ppcb-20250331_def.xml EX-101.DEF 450805
10 XBRL LABEL FILE ppcb-20250331_lab.xml EX-101.LAB 660486
11 XBRL PRESENTATION FILE ppcb-20250331_pre.xml EX-101.PRE 573575
88 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 3158332
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-282886 | Film No.: 251010453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)